Publications

Click on the publication title to view the full text (in pdf format).

Shephard M, Allen G, Paizis K, Barbara J, Batterham M and Vanajek A. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio. Rural and Remote Health 2006; 6: Article 591 (on-line).

Shephard MDS and Gill JP. The analytical quality of point-of-care testing in the ‘QAAMS’ model for diabetes management in Australian Aboriginal medical services. Clinical Biochemist Reviews 2006; 27:185-190.

Shephard M. Clinical and cultural effectiveness of the ‘QAAMS’ point-of-care testing model for diabetes management in Australian Aboriginal medical services. Clinical Biochemist Reviews 2006; 27: 161-170.

Shephard M, Mazzachi B, Shephard A, Burgoyne T, Dufek A, Ahkit J, Mills D and Dunn D. Point-of-care testing in Aboriginal hands – a model for chronic disease prevention and management in Indigenous Australia. Point-of-Care: The Journal of Near-Patient Testing and Technology 2006; 5: 168-176.

Shephard M. Point-of-Care Testing Trial in General Practice in Australia. Point-of-Care: The Journal of Near-Patient Testing and Technology 2006; 5: 192.

Shephard M. Analytical goals for point-of-care testing used for diabetes management in Australian health care settings outside the laboratory. Point-of-Care: The Journal of Near-Patient Testing and Technology 2006; 5: 177-185.

Shephard M and Whiting M. Assessment of the practicability and analytical performance of a point-of-care affinity chromatography haemoglobin A1c analyser for use in the non-laboratory setting. Annals of Clinical Biochemistry 2006; 43; 513-515.

Shephard MDS and Gill JP. An innovative Australian point-of-care model for urine albumin:creatinine ratio testing that supports diabetes management in indigenous medical services and has international application. Annals of Clinical Biochemistry 2005; 42:208-215.

Martin D, Shephard M, Freeman H, Jones TW, Davis E and Maguire G. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community. Medical Journal of Australia 2005; 182: 524-527.

Shephard M, Mazzachi B, Shephard A, McLaughlin K, Barnes G and Denner B. The impact of point of care testing on diabetes services along Victoria’s Mallee Track. Results of a community-based diabetes risk assessment and management program. Rural and Remote Health 5:371. (On-line), 2005.

Shephard MDS. Point-of-care testing in the Indigenous Rural Environment – the Australasian Experience. Chapter 29 p 293-301. In: Point-of-Care Testing. Price C, Hicks J and St John A (eds). AACC (American Association of Clinical Chemistry) Press, Washington DC, July 2004.

Shephard MDS. Analytical performance criteria for point-of-care testing instruments. Part 10, pages 101-140. In: Standards for Point of Care Testing in general practice. Incorporating POCT Trial Guidelines. Australian Government Department of Health and Ageing, Canberra, June 2004.

Shephard MDS. Point-of-care testing in the Indigenous Rural Community. Clinical Biochemist Newsletter 2004; 153 (June): 26-31.

Shephard MDS. How to set up and manage a point-of-care testing service. Clinical Biochemist Newsletter 2004; 153 (June): 36-41.

Shephard MDS and Gill J. Results of an Innovative Education, Training and Quality Assurance Program for Point-of-Care HbA1c Testing using the Bayer DCA 2000 in Australian Aboriginal Community Controlled Health Services. Clinical Biochemist Reviews 2003; 24: 123-131.

Shephard MDS and Mundraby K. Assisting diabetes management through point-of-care HbA1c testing – the ‘QAAMS’ program for Aboriginal health workers. Aboriginal and Islander Health Worker Journal 2003; 27 (4): 12-18.

Shephard MDS, Allen GG, Barratt LJ, Paizis K, Brown M, Barbara JAJ, McLeod G, Vanajek A.Albuminuria in a remote South Australian Aboriginal community: results of a community-based screening program for renal disease. Rural and Remote Health 2003; 3 (online) 8 February 2003. Available from http://rrh.deakin.edu.au.

Shephard M. Point-of-care testing in the Aboriginal community. Australian Journal of Medical Science 2003; 24: 10-16.

Jones R, Mazzachi B, Shephard M. Point-of-Care in Aboriginal Hands. Aboriginal and Islander Health Worker Journal 2002; 26 (6): 13-16.

Zeunert S, Cerro N, Boesch L, Duff M, Shephard MDS, Jureidini KF and Braun J. Nutrition project in a remote Australian Aboriginal community. Journal of Renal Nutrition 2002; 12: 102-106.

Shephard MDS and Tallis G. Assessment of the point-of-care Cholestech Lipid Analyser for lipid screening in Aboriginal communities. Australian Journal of Medical Science 2002; 23: 4-10.

Shephard MDS and Allen GG. Screening for renal disease in a remote Aboriginal community using the Bayer DCA 2000. Australian Journal of Medical Science 2001; 22: 164-170.

Shephard MDS, Brown M, Hudson M, Riessen C and Braun J. The Umoona Kidney Project. Aboriginal and Islander Health Worker Journal 2000; 24 (2): 12-15.

Shephard MDS, Barratt L, Simpson-Lyttle W. Is the Bayer DCA 2000 acceptable as a screening instrument for the early detection of renal disease? Annals of Clinical Biochemistry 1999; 36: 393-394.

Mark Shephard delivering a lecture at the 6th International Conference on Diabetes in Indigenous Peoples. Cairns, Qld, 2004

Mark Shephard delivering a lecture at the 6th International Conference on Diabetes in Indigenous Peoples. Cairns, Qld, 2004

Mark Shephard presenting the AACB Regional Travelling Lecture in Bunbury, WA, 2005

Mark Shephard presenting the AACB Regional Travelling Lecture in Bunbury, WA, 2005